Ewan A Langan (E A Langan, E A Langan)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 17

Top Topics

Respiratory Syndrome Coronavirus

Replacement Therapy

Top Venues

The British journal of dermatology

Clinical and experimental dermatology

Skin health and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Jasper N Pruessmann, Iakov Shimanovich, Ewan A Langan, D Zillikens, R J Ludwig, Katharina Boch
Annular plaques on the back. Clinical and experimental dermatology 47 (3) (2022)
Jonas K Kurzhals, Baerbel Christiansen, Ewan A Langan
Bringing the risk of dermatoscope-related infection under the magnifying glass. Clinical and experimental dermatology 47 (9) (2022)
Ewan A Langan, Axel Künstner
The gastrointestinal microbiome and psoriasis: more food for thought. The British journal of dermatology 187 (2) (2022)
Jonas K Kurzhals, Gina Klee, Hauke Busch, Victoria Hagelstein, Detlef Zillikens, Patrick Terheyden, Ewan A Langan
The impact of the Covid-19 pandemic on quality of life in skin cancer patients. PloS one 16 (8) (2021)
Ewan A Langan, Kaja Budner, Detlef Zillikens, Patrick Terheyden
Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report. Medicine 100 (16) (2021)
Shehnaz Ahmed, Alexa R Shipman, George W M Millington, Ewan A Langan, John R Ingram
Consent for publication: why it matters now more than ever. The British journal of dermatology 183 (3) (2021)
Katharina Boch, Sören Dräger, Detlef Zillikens, Christoph Hudemann, Christoph M Hammers, Sabrina Patzelt, Enno Schmidt, Ewan A Langan, Rüdiger Eming, Ralf J Ludwig, Katja Bieber
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice. PloS one 16 (11) (2021)
Ewan A Langan
Moving to the forefront of open access publishing in dermatology. Skin health and disease 1 (1) (2020)
J Kurzhals, P Terheyden, Ewan A Langan
Immune checkpoint inhibition in the era of COVID-19. Clinical and experimental dermatology 46 (1) (2020)
Shehnaz Ahmed, Alexa R Shipman, George W M Millington, Ewan A Langan, John R Ingram
Consent for publication: why it matters now more than ever. Clinical and experimental dermatology 45 (8) (2020)
Shehnaz Ahmed, Alexa R Shipman, George W M Millington, Ewan A Langan, John R Ingram
Consent for publication: Why it matters now more than ever? Skin health and disease 1 (1) (2020)
Ewan A Langan, Eleanor Hinde, Ralf Paus
Prolactin as a candidate sebotrop(h)ic hormone? Experimental dermatology 27 (7) (2019)
Ewan A Langan, A Künstner, M Miodovnik, D Zillikens, D Thaçi, J F Baines, S M Ibrahim, W Solbach, J K Knobloch
Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. The British journal of dermatology 181 (6) (2019)
Ewan A Langan, Christiane Kümpers, Victoria Graetz, Sven Perner, Detlef Zillikens, Patrick Terheyden
Intralesional interleukin-2: A novel option to maximize response to systemic immune checkpoint therapy in loco-regional metastatic melanoma. Dermatologic therapy 32 (3) (2019)
Ewan A Langan
Prolactin and human skin-the effects of sex and site on expression and function. Endocrine 59 (3) (2018)
Ewan A Langan, C E M Griffiths, W Solbach, J K Knobloch, D Zillikens, D Thaçi
The role of the microbiome in psoriasis: moving from disease description to treatment selection? The British journal of dermatology 178 (5) (2018)
Ewan A Langan, V Grätz, F Billmann, D Zillikens, P Terheyden
Does the gastrointestinal microbiome contribute to the 'obesity paradox' in melanoma survival? The British journal of dermatology 179 (1) (2018)